News

GEN - Genetic Engineering and Biotechnology News4h
BMS, BioNTech Ink Up-to-$11B Cancer Bispecific Antibody Collaboration
BMS will co-develop and co-commercialize BioNTech’s bispecific antibody BNT327 for solid tumors in a deal worth up to $11.1B ...
1BNTX : 12 Analysts Have This To Say About BioNTech
In the assessment of 12-month price targets, analysts unveil insights for BioNTech, presenting an average target of $138.7, a ...
Contract Pharma14h
BioNTech, BMS Partner to Develop & Commercialize BNT327 for Solid Tumors
BioNTech SE and BMS have partnered for the global co-development and co-commercialization of BNT327 across numerous solid ...
Why BioNTech Stock Soared Today
Bristol Myers Squibb just agreed to shower BioNTech with cash. BioNTech ( BNTX 20.01%), one of the companies made famous for ...
BioNTech-Aktie steigt - Bristol zahlt bis zu $11,1 Mrd. in Krebsmedikament-Deal
Bristol-Myers Squibb wird BioNTech bis zu 11,1 Milliarden Dollar (9,7 Milliarden Euro) für die Lizenzierung eines ...
Truist Lifts BioNTech (BNTX) Price Target After New Partnership
This decision came after the company entered into an agreement with Bristol Myers Squibb for the co-development and ...
These Stocks Are Moving the Most Today: Cleveland-Cliffs, Steel Dynamics, Tesla, Blueprint Medicines, Moderna, BioNTech, and More
Shares of steel companies soar after President Donald Trump says he will raise tariffs on imported steel to 50% from 25%.
Stock Movers: BioNTech, Boeing, Nucor
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...